Novel (New) Oral Anticoagulants (NOACs)

Return to all Family Medicine Update Sessions.

Estimated time to complete session: 1 hour

Learning Objectives

1. Utilize a systematic process of care, including initiation and assessment of therapy and dosing adjustments, to optimize effectiveness and minimize adverse effects of patients taking warfarin.

2. Consider new agents in patients with atrial fibrillation and at least one other risk factor for stroke that do not require frequent laboratory monitoring and are as effective as warfarin for prevention of stroke or systemic embolism and have comparable risks of major bleeding.

3. Develop collaborative care plans with patient education to counsel patients on safe and effective self-administration of anticoagulants, emphasizing self-monitoring to prevent complications.

4. Establish or revise existing practice-level protocols for anticoagulation management, based on current evidence-based recommendations and guidelines, including having clearly defined staff roles and responsibilities.

Additional Information

Technical Requirements: 

View technical requirements (opens in a new window).

CME Credit Information: 

View CME credit information (opens in a new window).

AAFP Staff: 

View AAFP staff list (opens in a new window).

Disclosures: 

View disclosures and disclaimers (opens in a new window).

Course summary
Available credit: 
  • 1.00 AAFP prescribed
Course opens: 
03/25/2014
Course expires: 
02/09/2018

Robert Dachs, MD, FAAFP, Vice-Chairman, Department of Emergency Medicine, Ellis Hospital, Schenectady, New York; Clinical Associate Professor and Director of Research, Ellis Hospital Family Medicine

Available Credit

  • 1.00 AAFP prescribed

Accreditation Period

Course opens: 
03/25/2014
Course expires: 
02/09/2018
Please login or register to take this course.